Singular Genomics(us:OMIC)

    19.55

    -1.96%

    Updated on 2024-12-22

    Open:20.18
    Close:19.55
    High:20.55
    Low:19.50
    Pre Close:19.94
    Volume:17024.00
    Amount:344697.19
    Turnover:0.68%
    Shares:2.51M
    MarketCap:49.15M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-304470982328.49%21326
    2024-03-31488460531.14%2717
    2023-12-31542620148535.49%5821
    2023-09-30632700773036.82%11136
    2023-06-30813284955644.95%151640
    2023-03-31833583215949.77%51640
    2022-12-31913718156551.75%192333
    2022-09-30874020311256.38%112533
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Deerfield Management Company, L.P. (Series C)1661460.22%0
    2024-03-31Arch Venture Management, Llc1266180.17%0
    2024-03-31Qvidtvm Management Llc835480.11%62348.06%
    2024-03-31Ubs Group Ag736390.10%10.00%
    2024-03-31Perceptive Advisors Llc708890.10%0
    2024-03-31Fmr Llc706470.10%0
    2024-03-31Vanguard Group Inc624130.08%0
    2024-03-31Casdin Capital, Llc441250.06%0
    2024-03-31Blackrock Inc.246210.03%-3163-11.38%
    2024-03-31Orbimed Advisors Llc180210.02%0

    About

    Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
    Address:3010 Science Park Road

    Market Movers